Aadi Bioscience, Inc. (AADI) Tops Q3 EPS by 12c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q3 EPS of ($0.60), $0.12 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $5.96 million versus the consensus estimate of $6.62 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion
• Playboy to buy back 16.6M shares from Fortress at $1.05 each